Americans Who Don't Know They Have Diabetes Incur $18 Billion in Health Expenses Each Year
25 Percent Unaware They Have the Disease; Undiagnosed Diabetes Costs $2,864 Per Person Annually In Medical Services, Lost Productivity WASHINGTON, May 20 /PRNewswire/ -- Americans living with undiagnosed diabetes incur an estimated $18 billion in healthcare expenditures each year, or $2,...LCA-Vision New Excimer Laser Strategy to Reduce Operating Expenses in Excess of $3 Million Annually
CINCINNATI, March 10 /PRNewswire-FirstCall/ -- LCA-Vision Inc. (Nasdaq: LCAV ) today announced that following a rigorous clinical comparison of excimer laser platform technologies, the Company has finalized plans to reduce the number of platforms at each of its Lasik Plus (R) vision centers from...WellPoint to Reduce Operating Expenses for Continued Long-Term Success
INDIANAPOLIS, Jan. 16 /PRNewswire-FirstCall/ -- WellPoint, Inc. (NYSE: WLP ) today announced it is streamlining its administrative cost structure in response to the ongoing economic downturn as it continues to manage its business for long-term success. As part of this initiative, WellPoint ...Retrospective study analyzes expenses of osteoporosis-related fracture over 3 years
Montreal, September 15, 2008 In a retrospective analysis of more than 30,000 female Medicare patients 65 years and older, osteoporosis fractures resulted in fracture-related medical expenses of $15,522 per person over three years. The study, presented at the American Society for Bone and Mineral...Dynatronics Reduces Annual Expenses by $1.9 Million
SALT LAKE CITY, May 2 /PRNewswire-FirstCall/ -- Dynatronics Corporation (Nasdaq: DYNT ) today announced that it has completed measures designed to reduce expenses by an estimated $1.9 million annually. These cost savings were achieved primarily by a reduction of approximately 20 percent of ...IRC Reports Claimed Medical Expenses for Auto Injury Claimants Far Outpace Inflation
MALVERN, Pa., Feb. 13 /PRNewswire-USNewswire/ -- A new study by the Insurance Research Council (IRC) has found that medical expenses reported by auto injury claimants continue to rise faster than the rate of inflation. Average claimed economic losses (which include expenses for medical care, l...Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
...8. Isis' financial results in 2009 reflect higher expenses associated with the expansion of the Company's pro...he third quarter of this year. Operating expenses On a pro forma basis, operating expenses for the three and six months ended June 30, 2009 w...NewCardio Announces Master Services Agreement With Dedicated Phase I
...tal as, and when, needed, and on acceptable terms and general economic conditions specific to our industry, any of which could impact sales, costs and expenses and/or planned strategies and timing. Information concerning factors that could cause our actual results to differ materially from these forward-looki...Nektar Therapeutics Reports Second Quarter 2009 Financial Results
...compared to a year ago. Total operating costs and expenses were down 19% to $43.5 million in the second quart... the first half of 2009, total operating costs and expenses were down 28% to $83.5 million as compared to $115... ------ Total operating costs and expenses 43,468 53,759 83,477 115,640 ...Cyberonics Provides Update on Depression Post-Approval Study
...aims and potential litigation; reliance on single suppliers and manufacturers for certain components; the accuracy of management's estimates of future expenses and sales; the results of the previously disclosed governmental inquiries; the potential identification of material weaknesses in our internal control...Spherix Reports First Quarter 2009 Earnings
...rix Consulting"). Research and development expenses were $1.6 million in the quarter, up from $1.0 mil...previous year's quarter. The increase in R&D expenses is related to the expansion of the Phase 3 trial to India. The Company's R&D expenses for both years consisted of costs for both the Pha...BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
...ngements. Research and development (R&D) expenses were $11.3 million for the three months ended Marc...ths ended March 31, 2008. The decrease in R&D expenses was primarily attributable to a reduction in clini...grams. General and administrative (G&A) expenses were $2.5 million for the three months ended March...Bionovo Announces First Quarter 2009 Highlights and Financial Results
... First Quarter Results Total operating expenses for the three months ending March 31, 2009 were $4...lion for the same period in 2008. Total operating expenses for the first quarter included one-time expenses associated with the relocation of the Company's he...Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status
...ds Ended March 31, 2009 and 2008 GAAP operating expenses were $16.4 million and $19.2 million in the quarte...pment of AZ-004, the Company expects to reduce its expenses by approximately $21.5 million, net of severance c... - - Total operating expenses 16,357 19,155 ...Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update
...uarter ended March 31, 2008. Total operating expenses for the quarter ended March 31, 2009, were $12.2 m...the quarter ended March 31, 2008. Total operating expenses for the first quarter of 2009 include a charge of ...tive March 31, 2009. Research and development expenses were $8.1 million for the quarter ended March 31, ...Transcept Pharmaceuticals to Report First Quarter 2009 Results
...ue to various risks and uncertainties, including, but not limited to, a significant delay in FDA approval of Intermezzo(R) ; unanticipated additional expenses in connection with the commercialization of Intermezzo(R) ; Transcept product candidates may have unexpected adverse side effects or inadequate thera...Mobile Catheterization Laboratories Serving Hospital Networks
Description:...ersonnel. This allows hospitals and physicians to offer cardiovascular care services while avoiding the substantial capital expenditures and operating expenses needed to purchase and operate the equipment required to perform these services....GenomeLab SNPstream Genotyping System
Features:...rate sample tracking and reporting. And our standardized reaction conditions mean no optimization is necessary. Cost-effective -- By lowering PCR expenses and improving efficiency, the 12-plex power built into the GenomeLab SNPstream reduces cost per genotype....Aware, Inc. Reports Second Quarter 2009 Financial Results
...ative (1) 1,216 1,285 2,429 2,478 ----- ----- ----- ----- Total costs and expenses 7,410 7,735 14,237 15,268 Loss from operations (1,646) (1,568) (3,900) (3,224) Interest income ...Aware, Inc. Reports First Quarter 2009 Financial Results
...elling and marketing (1) 1,081 969 General and administrative (1) 1,213 1,193 Total costs and expenses 6,826 7,532 Net loss from operations (2,253) (1,656) Interest income ...Aware, Inc. Reports First Quarter 2009 Financial Results
...elling and marketing (1) 1,081 969 General and administrative (1) 1,213 1,193 Total costs and expenses 6,826 7,532 Net loss from operations (2,253) (1,656) Interest income ...Aware, Inc. Announces Final Results of Dutch Auction Tender Offer
... (including the associated preferred share purchase rights) at a purchase price of $2.50 per share, for a total cost of $8,750,630 (excluding fees and expenses relating to the tender offer). The shares accepted for purchase represent approximately 15% of Aware's outstanding shares of common stock as of April ...Aware, Inc. Announces Preliminary Results of Dutch Auction Tender Offer
...ding the associated preferred share purchase rights) at a price of $2.60 per share, for a total cost of approximately $9.6 million (excluding fees and expenses relating to the tender offer). The approximately 3,696,072 shares expected to be purchased are comprised of the 3,500,000 shares Aware offered to purc...Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results
... 401 205 1,064 525 Gross profit 442 595 1,337 1,620 Total operating expenses 806 1,037 3,581 3,813 Operating loss (364) (442) (2,244) (2,193) Other income (expe...BIO-key(R) Reports Profitability for Fourth Quarter and Full Year 2008
... The company's continued emphasis on cost containment enabled operating expenses to decrease by 17% to $2.5 million for the fourth quarter of 2008, compared...07. The company's commitment to cost containment resulted in operating expenses decreasing by 19% to $11.0 million for the year ended December 31, 2008 com...Aware, Inc. Reports Fourth Quarter and 2008 Financial Results
...h quarter. While we have a strong cash position, we are closely monitoring expenses across all elements of our business. We remain optimistic that despi...16 967 5,209 4,237 Total costs and expenses 7,326 7,053 29,888 28,267 Net income (loss...LocatePLUS Announces Election of Independent Board
...ePLUS: Statements in this press release concerning the Company's business outlook or future economic performance, anticipated profitability, revenues, expenses or other financial items, and network or service offering growth, together with other statements that are not historical facts, are "forward-looking s...Cell Therapeutics Net Loss Declines as Operating Expenses Decrease By 58% in Third Quarter 2008
Zevalin(R) on Track for Break-Even in 2008 SEATTLE, Nov. 7 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) reported financial results for the quarter ended September 30, 2008. Total revenues for the quarter were $2.6 million compared to $20,000 for...LifeStem International, Inc. Announces Increased Revenues, Decreased Operating Expenses
LAGUNA HILLS, Calif., May 14 /PRNewswire-FirstCall/ -- LifeStem International, Inc., (OTC Bulletin Board: LSTM), formerly CalbaTech, Inc., an emerging life sciences company concentrating on providing products and platforms to the research market for biotech and pharmaceutical companies and to ...SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results
...e our capital by limiting clinical and development expenses to our ibuprofen and pseudoephedrine lead products... have made significant reductions to our operating expenses so far this year and are continuing to evaluate ad...ionship with Perrigo. Marketing and selling expenses decreased 79%, or $151,579 to $39,468 for the thre...Novavax Reports Second Quarter 2009 Financial Results
... 5,454 6,410 ----- ----- ----- ----- Total operating costs and expenses 7,859 8,546 15,017 16,224 ----- ----- ------ ------ Loss from cont...Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results
...me period in 2008. Research and development expenses for the second quarter of 2009 were $1,376,253 com...d $99,532, respectively. Research and development expenses for the six months ended June 30, 2009 were $3,698...8, respectively. General and administrative expenses for the second quarter of 2009 totaled $392,559 co...NeurogesX Reports Second Quarter 2009 Results
...ter 2009 Financial Results Total operating expenses for the second quarter of 2009 were approximately ..., but continued to defer non-clinical and clinical expenses for all other development programs in order to foc...rogesX' product candidates; expectations regarding expenses and cash burn rate as well as receipt of any payme...American Oriental Bioengineering Reports Second Quarter 2009 Financial Results
... 3,011,486 3,262,877 Other payables and accrued expenses 14,251,673 19,766,652 Taxes payable ...74 1,010,461 3,709,189 1,987,671 Total operating expenses 23,342,053 21,403,858 40,545,470 35,717,800 INCOME FRO...AutoImmune Inc. Reports 2009 Second Quarter Financial Results
...000 180,000 386,000 368,000 ------- ------- ------- ------- Total costs and expenses 245,000 260,000 504,000 539,000 ------- ------- ------- ------- Interes...GenVec Reports Second Quarter 2009 Financial Results
...fforts as compared to the comparable prior year periods. Operating expenses were $8.6 million and $17.8 million for the three-month and six-month perio... ----- ----- ----- ----- Total operating expenses 8,549 10,645 17,768 20,778 -...